α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth

One of the least-investigated areas of brain pathology research is glycosylation, which is a critical regulator of cell surface protein structure and function. β-Galactoside α2,6-sialyltransferase (ST6GAL1) is the primary enzyme that α2,6 sialylates N-glycosylated proteins destined for the plasma me...

Descripción completa

Detalles Bibliográficos
Autores principales: GC, Sajina, Tuy, Kaysaw, Rickenbacker, Lucas, Jones, Robert, Chakraborty, Asmi, Miller, C. Ryan, Beierle, Elizabeth A., Hanumanthu, Vidya Sagar, Tran, Anh N., Mobley, James A., Bellis, Susan L., Hjelmeland, Anita B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675560/
https://www.ncbi.nlm.nih.gov/pubmed/36345944
http://dx.doi.org/10.1172/jci.insight.158799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675560/
https://www.ncbi.nlm.nih.gov/pubmed/36345944
http://dx.doi.org/10.1172/jci.insight.158799

Ejemplares similares